UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

The American journal of gastroenterology, 2010-03, Vol.105 (3), p.501-523

2010

Volltextzugriff (PDF)

The Role of the Gastroenterologist in Obesity Management: Now Is the Right Time for Our Involvement

The American journal of gastroenterology, 2024-06, Vol.119 (6), p.1001-1006

2024

Volltextzugriff (PDF)

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

The New England journal of medicine, 2010-04, Vol.362 (15), p.1383-1395

2010

Volltextzugriff (PDF)

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

The American journal of gastroenterology, 2004-07, Vol.99 (7), p.1371-1385

2004

Volltextzugriff (PDF)

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease

The American journal of gastroenterology, 2006-10, Vol.101 (10), p.2218-2222

2006

Volltextzugriff (PDF)

Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes

The American journal of gastroenterology, 2008-05, Vol.103 (5), p.1203-1209

2008

Volltextzugriff (PDF)

Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1730-1732

Kornbluth, Asher

2020

Volltextzugriff (PDF)

Erratum: Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

The American journal of gastroenterology, 2010-03, Vol.105 (3), p.500-500

2010

Volltextzugriff (PDF)

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

The New England journal of medicine, 1994-06, Vol.330 (26), p.1841-1845

1994

Volltextzugriff (PDF)

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

The American journal of gastroenterology, 2006-07, Vol.101 (7), p.1546-1550

2006

Volltextzugriff (PDF)

Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference

Inflammatory bowel diseases, 1998-11, Vol.4 (4), p.328-329

Kornbluth, A

1998

Volltextzugriff (PDF)

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

Clinical gastroenterology and hepatology, 2012-09, Vol.10 (9), p.1002-1007

2012

Volltextzugriff (PDF)

Clinical scenarios in IBD: Optimizing the use of conventional and biologic agents

Inflammatory bowel diseases, 2010-12, Vol.16 (S1), p.S1-S11

2010

Volltextzugriff (PDF)

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1779-1785

2020

Volltextzugriff (PDF)

Mucosal Dysplasia in Ileal Pelvic Pouches After Restorative Proctocolectomy

Diseases of the colon & rectum, 2007-06, Vol.50 (6), p.825-831

2007

Volltextzugriff (PDF)

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Gut, 2014-01, Vol.63 (1), p.88-95

2014

Volltextzugriff (PDF)

Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis

The American journal of gastroenterology, 2017-11, Vol.112 (11), p.1719-1721

2017

Volltextzugriff (PDF)

A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business

Inflammatory bowel diseases, 2016-10, Vol.22 (10), p.2513-2526

2016

Volltextzugriff (PDF)

Response to Dr. Spada and Colleagues

The American journal of gastroenterology, 2007-07, Vol.102 (7), p.1543-1544

2007

Volltextzugriff (PDF)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Inflammatory bowel diseases, 2022-01, Vol.28 (Supplement_1), p.S104-S105

2022

Volltextzugriff (PDF)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Gut, 2012-04, Vol.61 (4), p.535-542

2012

Volltextzugriff (PDF)

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Inflammatory bowel diseases, 2011-02, Vol.17 (2), p.599-604

2011

Volltextzugriff (PDF)

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease

Expert review of gastroenterology & hepatology, 2015-04, Vol.9 (4), p.497-505

2015

Volltextzugriff (PDF)

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry

Inflammatory bowel diseases, 2022-07, Vol.28 (7), p.1126-1129

2022

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

KollektionRCN full-text journals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(85)

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(54)
Science & Technology
(54)
Humans
(51)
Gastroenterology & Hepatology
(50)
Female
(29)
Male
(27)
Adult
(26)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Gastroenterology
(20)
Middle Aged
(19)
Gastroenterology. Liver. Pancreas. Abdomen
(15)
Other Diseases. Semiology
(15)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(15)
Crohn's Disease
(14)
Inflammatory Bowel Disease
(14)
Treatment Outcome
(14)
Crohn Disease - Drug Therapy
(12)
Ulcerative Colitis
(12)
Colitis, Ulcerative - Drug Therapy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

The Role of the Gastroenterologist in Obesity Management: Now Is the Right Time for Our Involvement

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease

Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes

Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?

Erratum: Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

Clinical scenarios in IBD: Optimizing the use of conventional and biologic agents

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Mucosal Dysplasia in Ileal Pelvic Pouches After Restorative Proctocolectomy

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis

A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business

Response to Dr. Spada and Colleagues

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry

Aktive Filter

Suchergebnisse filtern